Skip to main content
Fig. 2 | BMC Health Services Research

Fig. 2

From: Economic impact of implementing prescription of single-inhaler triple therapies versus current multiple-inhaler triple therapies for COPD in the Apulia Region

Fig. 2

Market shares of the triple therapies currently used in the Apulia Region. Abbreviations: ICS: inhaled corticosteroids; LABA: long-acting beta2-agonists; LAMA: long-acting antimuscarinic agents; FF: fluticasone furoate; VI: vilanterol; UMEC: umeclidinium bromide; SAL: salmeterol; FP: fluticasone propionate; TIO: tiotropium bromide; ACL: aclidinium bromide; BDP: beclomethasone dipropionate; FOR: formoterol fumarate; BUD: budesonide; GB: glycopyrronium bromide; IND: indacaterol; OLO: olodaterol; “/”: drugs combination in a single inhaler; “+”: addition of a medication dispensed by another inhaler

Back to article page

BMC Health Services Research

ISSN: 1472-6963

Contact us